FDA Drug Application (061866) for ANSPOR by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number061866
Product Number001
FormFOR SUSPENSION;ORAL
Dosage125MG/5ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameANSPOR
Active IngredientCEPHRADINE

Active IngredientCount
List of drugs with Active Ingredient CEPHRADINE6


Back to FDA Applications sponsored by GLAXOSMITHKLINE